Trial Profile
Efficacy and safety of peginterferon alfa-2a + ribavirin +/- raloxifene in the treatment of chronic genotype 1b hepatitis C in postmenopausal women.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 May 2012
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 11 May 2012 New trial record